Nayeon Kim

Nayeon Kim

Auto-generated profile, based on publicly available information

Nayeon Kim

Department of Science Education Ewha Womans University Seoul Republic of Korea

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HSHa-Yeon Song
Ha-Yeon Song
NKNayeon Kim
Nayeon Kim
DKDae-Hyuk Kim
Dae-Hyuk Kim
JKJung-Mi Kim
Jung-Mi Kim
Isogenic virus-cured and virus-infected fungal strains were previously obtained and compared to investigate mycoviral diseases and, specifically, the influence of viral infection on the vegetative growth of Pleurotus ostreatus. The present study demonstrated that infection with mycovirus PoV-ASI2792 (PoV) caused phenotypic and physiological changes in fungal cells and mycelia. The microscopically determined growth rate of the virus-infected strain was lower than that of the virus-cured strain, due to the conglomerate phenomenon during the mycelial growth process. An exploration of the viral effects of PoV on fruiting bodies yield showed significantly lower than that on virus-cured P. ostreatus. A colorimetric assay of polyphenol oxidase activity in the strains showed very weak activity in the virus-infected strain. To estimate the activity levels of enzymes related to the growth and fruiting body formation, the relative expression levels of genes encoding various extracellular enzymes such as Carbohydrate-Active Enzymes (CAZymes) were measured by quantitative RT-PCR. The expression levels of the assayed genes were significantly lower in virus-infected than in virus-cured P. ostreatus. Together, these results indicate that PoV infection affects the spawn growth and fruiting body formation of P. ostreatus via decreased expression and activity of some extracellular enzymes including lignocellulolytic enzymes.

12 January 2023 in Journal of Medicinal Food
Verified
Journal Article
Closed access
NKNayeon Kim
Nayeon Kim
CKChaeyeong Kim
Chaeyeong Kim
SRSoo Ho Ryu
Soo Ho Ryu
Jong-Sup BaeJong-Sup Bae
Jong-Sup Bae
High mobility group box protein 1 (HMGB1) is a biomolecule that acts as an alerting signal of late sepsis by accelerating the production of proinflammatory cytokines, and eventually leads to various inflammation-related symptoms. When released into plasma at high concentration, it disrupts precise diagnosis and prognosis and worsens the survival of patients with systemic inflammatory conditions. Jujuboside B (JB) is a natural compound pressed from the seed of Zizyphi Spinosi Semen , which is known for its medical efficacies in treating various conditions such as hyperlipidemia, hypoxia, and platelet aggregation. Nevertheless, the medicinal activity of JB on HMGB1-involved inflammatory response in vascular cells in the human body is still ambiguous. Therefore, we hypothesized that JB could regulate the lipopolysaccharide (LPS)-induced dynamics of HMGB1 and its mediated cascade in inflammatory responses in human umbilical vein endothelial cells (HUVECs). In this experiment, JB and HMGB1 were administered in that order. In vitro and in vivo permeability, and cell viability, adhesion, and excavation of leukocytes, development of cell adhesion molecules, and lastly production of proinflammatory substances were investigated on human endothelial cells and mouse disease models to investigate the efficacy of JB in inflammatory condition. JB substantially blocked the translocation of HMGB1 from HUVECs and controlled HMGB1-induced adhesion and extravasation of the neutrophils through LPS-treated HUVECs. Moreover, JB decreased the formation of HMGB1 receptors and continually prevented HMGB1-induced proinflammatory mechanisms by blocking transcription of nuclear factor-κB and synthesis of tumor necrosis factor-α. In conclusion, JB demonstrated preventive effects against inflammatory pathologies and showed the potential to be a candidate substance for various inflammatory diseases by regulating HMGB1-mediated cellular signaling.


30 April 2025 in Journal of Hazard Literacy
Verified
Journal Article
Open access
PDF file
NKNayeon Kim
Nayeon Kim
SKSeoungdong Kim
Seoungdong Kim
Gastric cancer (GC) remains a major global health challenge due to its aggressive nature and resistance to conventional therapies. (SAHA, vorinostat), a histone deacetylase (HDAC) inhibitor, exhibits potent anticancer effects in various malignancies. However, its specific mechanisms in GC require further elucidation. The current study aimed to clarify the anticancer potential of SAHA against GC, focusing on apoptosis induction, mitochondrial dysfunction, cell cycle alteration, and gene expression related to nucleotide metabolism and cell cycle progression. SAHA significantly reduced GC cell proliferation, with adenocarcinoma (AGS) cells showing a pronounced response. Further experiments with AGS cells demonstrated that SAHA treatment substantially increased late apoptotic cell populations and mitochondrial depolarization, indicating activation of mitochondrial-mediated apoptosis. Cell cycle analysis revealed an increased apoptotic subG1 fraction, linking apoptosis to disrupted cell cycle progression. Quantitative PCR analyses indicated that SAHA treatment markedly altered expression levels of key genes associated with nucleotide synthesis and cell cycle regulation. Specifically, thymidylate synthase (TYMS) expression was significantly downregulated, suggesting compromised DNA synthesis capacity. Conversely, thymidine phosphorylase (TYMP), involved in nucleotide salvage pathways, was notably upregulated. In conclusion, SAHA exerts significant anticancer activity in GC cells via apoptosis induction, mitochondrial dysfunction, cell cycle arrest, and modulation of nucleotide metabolism-related genes. These findings indicate the therapeutic potential of SAHA in GC management.